Theracryf (LON:TCF) Releases Earnings Results

Theracryf (LON:TCF) released its quarterly earnings results on Wednesday. The company reported GBX (6) earnings per share for the quarter, Digital Look Earnings reports. Theracryf had a negative return on equity of 99.97% and a negative net margin of 792.17%.

Theracryf Trading Down 1.4%

LON:TCF opened at GBX 0.21 on Friday. The stock has a 50 day moving average of GBX 0.21 and a two-hundred day moving average of GBX 0.23. Theracryf has a 12 month low of GBX 0.18 and a 12 month high of GBX 1.25. The firm has a market cap of £4.45 million, a P/E ratio of -0.58 and a beta of 1.42.

Theracryf Company Profile

TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in behavioural brain disorders. TheraCryf’s strategy is to generate compelling data sets with a goal of partnering its programmes with mid-size to large pharma.

Behavioural brain disorders such as opioid and alcohol abuse, binge eating disorder, anxiety and fatigue affect more than 50 million people worldwide.